PDS Biotechnology (NASDAQ:PDSB) just reported results for the fourth quarter of 2023. PDS Biotechnology reported earnings per share of -35 cents. This was above the analyst estimate for EPS of -44 ...
The government on Monday informed the Assembly that steps are being taken to enhance the number of ration sale depots across ...